share_log

SAB BIO Says Co Completed Phase 1 Enrollment For SAB-142 With No Observation Of Serum Sickness

Benzinga ·  Nov 7 06:33

The company remains on track for a topline Phase 1 data readout by the end of the year.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment